Jeffrey Gene Lee's Insider Trades & SAST Disclosures
Jeffrey Gene Lee's most recent trade in BlackRock Health Sciences Trust II was a trade of 291 Phantom Shares done . Disclosure was reported to the exchange on Jan. 31, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jeffrey Gene Lee.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Health Sciences ... | Jeffrey Gene Lee | Portfolio Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 291 | 291 | - | - | Phantom Shares | |
| BlackRock Health Sciences ... | Jeffrey Gene Lee | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 204 | 204 (0%) | 0% | - | Common Stock | |
| BlackRock Health Sciences ... | Jeffrey Gene Lee | Portfolio Manager | Sale or transfer of securities back to the company at price $ 43.68 per share. | 31 Jan 2023 | 204 | 0 (0%) | 0% | 43.7 | 8,911 | Common Stock |
| BlackRock Health Sciences ... | Jeffrey Gene Lee | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 128 | 257 | - | - | Phantom Shares | |
| BlackRock Health Sciences ... | Jeffrey Gene Lee | Portfolio Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 83 | 83 | - | - | Phantom Shares | |
| BlackRock Health Sciences ... | Jeffrey Gene Lee | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 75 | 75 | - | - | Phantom Shares | |
| BlackRock Health Sciences ... | Jeffrey Gene Lee | Portfolio Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 363 | 363 | - | - | Phantom Shares | |
| BlackRock Health Sciences ... | Jeffrey Gene Lee | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 71 | 71 (0%) | 0% | - | Common Stock | |
| BlackRock Health Sciences ... | Jeffrey Gene Lee | Portfolio Manager | Sale or transfer of securities back to the company at price $ 45.38 per share. | 31 Jan 2022 | 71 | 0 (0%) | 0% | 45.4 | 3,222 | Common Stock |
| BlackRock Health Sciences ... | Jeffrey Gene Lee | Portfolio Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 71 | 142 | - | - | Phantom Shares | |
| BlackRock Health Sciences ... | Jeffrey Gene Lee | Portfolio Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 203 | 203 | - | - | Phantom Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges